WhenToTest.org Develops Online Tools for Effective COVID-19 Testing - POCTRN

Center news

null WhenToTest.org Develops Online Tools for Effective COVID-19 Testing

WhenToTest.org Develops Online Tools for Effective COVID-19 Testing

New Resources Help Schools and Businesses Reduce the Risk of an Outbreak

BOSTON (July 20, 2021) — WhenToTest.org announced today the release of a revamped online platform to make it even easier for schools and employers to safely remain open or resume in-person operations. The website includes a decision support tool to assist leaders in determining how to implement an effective COVID-19 testing program for their institutions. Specific enhancements include: 

  • An improved interface to help guide leaders to determine what should influence their COVID-19 testing strategy, including how vaccination rates impact testing frequency 
  • Insights to help leaders compare different testing approaches, such as rapid tests, PCR tests, pooled tests, and how frequently the tests should be administered to a population 
  • Educational content for implementing a testing program 
  • A more streamlined experience for purchasing testing supplies through Project N95’s clearinghouse

The Consortia for Improving Medicine with Innovation and Technology (CIMIT) and the Massachusetts Institute of Technology Institute for Data Systems and Society (MIT IDSS) developed WhenToTest.org with support from the National Institutes of Health’s RADx Tech program. 

Nancy Gagliano, M.D., Implementation Lead, RADx Tech said, “When NIBIB supported the development of WhenToTest.org last fall, we wanted to provide organizations with clear guidance on how to mitigate the spread of COVID-19 in their organizations. Even with the rollout of vaccines, testing is still a critical tool to ensure COVID-19 stays in check, and this new website will give leaders comprehensive guidance and support to implement or improve on their testing programs.” 

“In just over one year, RADx has helped dramatically expand COVID-19 testing choices and capacity,” said Bruce Tromberg, Ph.D., director of the National Institute of Biomedical Imaging and Bioengineering, part of NIH. “WhenToTest.org can help organizations evaluate a wide range of options and build the right program specifically for their needs and budget.” 


About WhenToTest.org: WhenToTest.org is an online platform that supports organizations in establishing effective COVID-19 mitigation strategies. The platform contains an evidence-based modeling tool to help organizations determine their testing needs and a comprehensive set of educational resources. WhenToTest.org is a joint project between the Consortia for Improving Medicine with Innovation and Technology (CIMIT) and the Massachusetts Institute of Technology Institute for Data Systems and Society (MIT IDSS) with support from the National Institute of Health’s RADx Tech program.

Contact: Tracy McMahon

RADx: Rapid Acceleration of Diagnostics

In response to the COVID-19 pandemic, the Rapid Acceleration of Diagnostics (RADx®) initiative was formed to accelerate the development, validation, and commercialization of innovative point-of-care and home-based tests, as well as improvements to clinical laboratory tests, that can directly detect SARS-CoV-2, the virus that causes COVID-19.


In the News 

Two New Over-the-Counter At-Home COVID-19 Tests Brought to U.S. Market Quickly by Biden-Harris Administration

New HHS actions add to Biden administration efforts to increase access to easy-to-use over-the-counter COVID-19 tests

NIH RADx initiative expands COVID-19 testing innovation for additional types of rapid tests

The need for new test verification and regulatory support for innovative diagnostics

NIH-funded screening study builds case for frequent COVID-19 antigen testing

RADx partnerships speed new COVID testing

One Year of RADx Tech Success

Publication reveals essential ingredients of the groundbreaking NIH RADx national diagnostics effort 

Innovative COVID-19 Testing RADx Tech Reports Unveiled in Special Issue of IEEE Open Journal of Engineering in Medicine and Biology

Luminostics Announces FDA Authorization and Production Scale-Up of US-Manufactured Smartphone-Based COVID-19 Rapid Test

RADx Expects COVID-19 Portfolio to Accelerate an Era of At-Home Infectious Disease Testing (Login Required)

VIC Foundry, Inc. Receives NIH RADx Funding for Development of an At-home Molecular Diagnostic Test for COVID-19

Ceres Nanosciences Opens Advanced Particle Manufacturing Plant in Northern Virginia to Expand Nanotrap® Particle Manufacturing Capacity for COVID-19 Testing

COVID-19 Testing: Three Breakthrough Solutions in the RADx Initiative

NIH Director: Collaboration Amid Chaos, and Biden’s First 100 Days - How Francis Collins sees the COVID response changing with the new administration

The National Strategy From the COVID-19 Response and Pandemic Preparedness

Winners of HHS Design-a-thon to Develop Innovative Digital Health Tools for COVID-19 At-Anywhere Diagnostic Tests Announced

The Need for More and Better Testing for COVID-19